Procter & Gamble Co. (P&G;, NYSE: PG) is a Fortune 500 American multinational corporation headquartered in Downtown Cincinnati, Ohio that manufactures a wide range of consumer goods. It is 6th in Fortune's Most Admired Companies 2010 list. P&G; is credited with many business innovations including brand management and the soap opera.
Campaign Finance$6,355,691 Given
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
- Employee Color Block
- PAC Color Block
Republicans vs. Democratsin dollars. "Other" includes 3rd parties and organizations without official party affiliation.
State vs. Federalin dollars
Top PAC Recipients
- Employee Color Block
- PAC Color Block
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Procter & Gamble
Names of Lobbyists
Firm Hired Amount Procter & Gamble $51,798,362
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Environment & Superfund,
- Chemical Industry,
- Medicare & Medicaid,
- Foreign Relations,
- Law Enforcement & Crime,
- Consumer Product Safety
Most Frequently Disclosed Bills
Bill No. Title H.R.4213 Tax Extenders Act of 2009 S.3551 Fiscally Responsible Relief for Our States Act of 2010 H.R.2735 To amend the Internal Revenue Code of 1986 to make permanent the look-through treatment of payments between related controlled foreign corporations. S.510 FDA Food Safety Modernization Act S.2191 S.2355 S.2356 S.2357 S.2358 S.2363
RegulationsMentioned in 376 dockets; Submitted to 26 dockets
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "Procter & Gamble" in public comments on proposed federal regulations.
Documents Submitted by the Organization
View all submissions data for Procter & Gamble
- Toggle 5 FDA Over-the-Counter Cough and Cold Medications for Pediatric Use; Notice of Public Hearing 2008
- Toggle 3 FDA Health-Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use 1975
- Toggle 2 FDA Draft Guidance for Industry and Food and Drug Administration Staff; The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]; Availability 2011
- Toggle 2 FAA Notice of Proposed Modification to the June 1, 2006 MOA FAA/Subscriber Memorandum of Agreement for ASDI/NASSI Industry Access and Request for Comments 2011
- Toggle 2 FDA Medical Devices 1976
- Toggle 1 USTR Request for Comments Concerning Free Trade Agreement With the Republic of Colombia 2009
- Toggle 1 FDA Strengthening the Center for Devices and Radiological Health’s 510(k) Review Process; Public Meeting; Request for Comments 2010
- Toggle 1 ESA Request for Information on the Family and Medical Leave Act of 1993 2006
- Toggle 1 FDA Joint Meeting of the Drug Safety and Risk Management Advisory Committee, Nonprescription Drugs Advisory Committee, and the Anesthetic and Life Support Drugs Advisory Committee; Notice of Meeting. 2009
- Toggle 1 FDA Microbial Safety of Produce; Public Meeting 1997
Mentions in Document Text
View all mentions data for Procter & Gamble
- Toggle 19 FDA Health-Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use 1975
- Toggle 11 FDA Over-the-Counter Cough and Cold Medications for Pediatric Use; Notice of Public Hearing 2008
- Toggle 9 FDA Sunscreen Drug Products 1978
- Toggle 9 FRA Environmental Review of Dakota Minnesota & Eastern Railroad Powder River Expansion Project Loan Application 2006
- Toggle 8 USCG Cabrillo Port Liquefied Natural Gas Deepwater Port License Application 2004
- Toggle 8 FDA PERMANENT LISTING OF D&C RED NO. 33 1987
- Toggle 8 EPA Prevention of Significant Deterioration (PSD) and Non-Attainment New Source Review (NSR): Baseline Emissions Determination, Actual-to-Future-Actual Methodology, Plantwide Applicability Limitations, Clean Units, Pollution Control Projects (Reconsideration) 2001
- Toggle 7 FDA Antigingivitis & Antiplaque-Related Claims 1981
- Toggle 6 FDA Petition Regarding the Review of Pending and Future Applications to Market PPIs OTC for Relief of Frequent Heartburn_CLOSED 2009
- Toggle 6 EPA Interstate Ozone Transport: Response to Court Decisions on the NOx SIP Call, NOx SIP Call Technical Amendments, and Section 126 Rules (Phase II) 2001
EPA Violations2 Enforcement Actions
Figures are based on data from the Environmental Protection Agency’s ECHO website. The ECHO database contains federal and state environmental enforcement actions. Data displayed here includes only those actions that began after 2000 and resulted in fines of over $1 million.
Actions where the company was the sole defendant are listed first. Actions where the company is one of multiple defendants are listed subsequently.
For more information see our EPA methodology page.
|Industrial Pollution Control (Ipc) (Cost Recovery Agmt)||Proctor & Gamble Manufacturing Company (+236 others)||2003||Jackson, Ms||$3,440,369|
|Fox River Nrda/Pcb Releases De Minimis (Cercla)||The Procter & Gamble Paper Products Co. (+10 others)||2009||Green Bay, Wi||$1,582,954|
Advisory Committees28 people on 23 committees
Data is based on disclosures required by the Federal Advisory Committee Act (FACA). Matches are based on the occurrence of the company name in the committee member affiliation. Variations in company names may cause some matches to be missed.
The table shows only the top 10 agencies. To search and download raw records from the complete dataset see the FACA data section.
Table shows employees of "Procter & Gamble" that sat on federal advisory committees.
- Toggle National Science Foundation 6 people on 5 committees
- Toggle Environmental Protection Agency 6 people on 5 committees
- Toggle Department of Health and Human Services 4 people on 4 committees
- Toggle Department of State 4 people on 3 committees
- Toggle Department of Commerce 3 people on 2 committees
- Toggle Office of the United States Trade Representative 2 people on 1 committee
- Toggle Commission on Civil Rights 1 person on 1 committee
- Toggle Department of Agriculture 1 person on 1 committee
- Toggle Agency for International Development 1 person on 1 committee